According to the current analysis of Reports and Data, the global Hemostasis Analyzers market was valued at USD 2,829.2 Million in 2018 and is expected to reach USD 6,304.1 million by the year 2026, at a CAGR of 10.4 percent.
The growing incidence and large economic burden of blood-related diseases and the rise in healthcare spending have resulted in the increased use of coagulation analyzers.
The increasing frequency of blood clotting disorders, coupled with increasing incidences of excessive blood loss in individuals during medical procedures are key factors boosting the growth of the global hemostasis analyzers market. Moreover, growing awareness regarding hemostasis among individuals in emerging economies, and technological advancements in hemostasis analyzers are some of the key factors propelling market growth in the industry.
Constant innovation in diagnostic technology and high R&D spending by major economies globally has led to the development of advanced instruments such as high throughput hemostasis analyzers. Moreover, high research and development spending, coupled with the growing awareness towards the advanced technologies are driving the growth of hemostasis analyzers market. Apart from this, the government of various developed and developing countries are investing heavily for developing the healthcare infrastructure. In addition to this, the developing countries under research are witnessing a paradigm shift and are focusing on acquiring and setting up advanced diagnostic equipment into their community healthcare facilities. All these factors drive the growth of global hemostasis analyzers market. However, the high cost of analyzers and slow adoption rate in developing economies along with stringent regulatory policies for validation of medical devices creates an obstacle for the entry of small players, are the major factors restraining the growth of this market.
One of the new areas where hemostasis analyzers are being used are in the military. Hemorrhage remains the leading cause of death in combat and the primary cause of preventable death after civilian trauma. Over the last 10 years, major improvements in hemostatic agents have resulted in new dressings that are replacing gauze as the standard of care for compressible hemorrhage. This has inspired a plethora of hemostatic products, some of which have been used in the combat and civilian sector. These developments are expected to positively affect the Hemostasis Analyzers market during the forecast period.
Key participants include Siemens Healthcare, Thermo Fisher Scientific, Instrumentation Laboratory Werfen Group, Sysmex Corporation, Roche Diagnostics, and Diagnostica Stago, among others
Request sample copy of this report @ https://www.reportsanddata.com/sample-enquiry-form/2208
Further key findings from the report suggest:
- Growing geriatric population and increased healthcare spending are some of the factors that support the growth of hemostasis analyzers market
- North America regional segment accounts for the largest share of 34.3% of the global Hemostasis Analyzers market and is expected to continue the trend over the forecast years. The factors that drive the growth of this segment are developed healthcare infrastructure, growing research and development activities, and increasing prevalence of hemostasis disorders in the region
- Mechanical hemostasis analyzers market is expected to witness significant growth market share due to its low cost and high accuracy
- Development of fully automated hemostasis analyzers provides a number of opportunities for emerging players. For instance, Symantec in 2014 launched Automated Blood Coagulation Hemostasis Analyzers CS-2500 that employs the multi-wavelength transmitted light detection system
You can Buy This Report from Here@ https://www.reportsanddata.com/checkout-form/2208
For the purpose of this report, Reports and Data has segmented the Hemostasis Analyzers market on the basis of product, test, technology, end use, and region:
Product (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Analyzer for Point-of-care testing
- Clinical laboratory analyzer
- Standards, Controls, and Calibration
- Automated Systems
- Semi-Automated Systems
Test Type (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Prothrombin Time
- Activated partial Thromboplastin Time
- Activated Clotting Time
- D Dimer
- Platelet Function
- Anti-factor Xa
- Heparin & Protamine response Test for ACT
- Other Coagulation Tests
Technology Type (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Other Technologies
Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/2208
End Use (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Diagnostic Centers
- Research Institutes
- Other end users
Regional Outlook (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- North America
- Rest of the Europe
- Asia Pacific
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America
Request for customization@ https://www.reportsanddata.com/request-customization-form/2208
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web: www.reportsanddata.com
Connect with us: Facebook | LinkedIn | Twitter
Browse more related reports: